Syndecan-1 in the Tumor Microenvironment

被引：7
|
作者：
Handra-Luca, Adriana [1 ,2 ]
机构：
[1] Univ Sorbonne Paris Nord, Serv Anat Pathol, Bobigny, France
[2] Univ Sorbonne Paris Nord, APHP GHU Avicenne, Bobigny, France
来源：
TUMOR MICROENVIRONMENT: EXTRACELLULAR MATRIX COMPONENTS - PT B | 2020年 / 1272卷
关键词：
Syndecan-1; Tumor; Stroma; Microenvironment; Pathology; Microscopy; Immunohistochemistry; Fibroblast; Vessels; Inflammatory cells; Extracellular matrix; Adenocarcinoma; Squamous cell carcinoma; Morphotype; Prognosis; STROMAL FIBROBLASTS; PROGNOSTIC VALUE; EXPRESSION; CELLS; CARCINOMAS; MYELOMA;
D O I：
10.1007/978-3-030-48457-6_3
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Syndecan-1 along with the other three syndecan proteins is present in the varied components of the tumor microenvironment: fibroblasts, inflammatory tumor immunity-associated cells, vessels, and extracellular matrix. Epithelial and non-epithelial tumors may show stromal syndecans. The main relevance of stromal syndecans as tumor biomarker resides in the relationships to tumor features such as type and differentiation as well as to prognosis.
引用
收藏
页码：39 / 53
页数：15
相关论文
共 50 条
  • [21] The expression of syndecan-1 in psoriatic epidermis
    Davor Tomas
    Majda Vučić
    Mirna Šitum
    Božo Krušlin
    Archives of Dermatological Research, 2008, 300 : 393 - 395
  • [22] Midkine and syndecan-1 levels correlate with the progression of malignant gastric cardiac adenocarcinoma
    Hu, Xiu-Feng
    Yao, Jun
    Gao, She-Gan
    Yang, Yan-Tong
    Peng, Xiu-Qing
    Feng, Xiao-Shan
    MOLECULAR MEDICINE REPORTS, 2014, 10 (03) : 1409 - 1415
  • [23] Syndecan-1 as an immunogene in Triple-negative breast cancer: regulation tumor-infiltrating lymphocyte in the tumor microenviroment and EMT by TGFb1/Smad pathway
    Zhong, Ying
    Li, Fangyuan
    Zhang, Sumei
    Yang, Zhenli
    Ren, Xinyu
    Cao, Xi
    Xu, Yali
    Guo, Dan
    Zhou, Yidong
    Mao, Feng
    Shen, Songjie
    Sun, Qiang
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [24] Clinical significance of syndecan-1 and versican expression in human epithelial ovarian cancer
    Kusumoto, Tomoyuki
    Kodama, Junichi
    Seki, Noriko
    Nakamura, Keiichiro
    Hongo, Atsushi
    Hiramatsu, Yuji
    ONCOLOGY REPORTS, 2010, 23 (04) : 917 - 925
  • [25] Induced expression of syndecan-1 in the stroma of head and neck squamous cell carcinoma
    Mukunyadzi, P
    Liu, K
    Hanna, EY
    Suen, JY
    Fan, CY
    MODERN PATHOLOGY, 2003, 16 (08) : 796 - 801
  • [26] Syndecan-1 in B lymphoid malignancies
    Sanderson, RD
    Borset, M
    ANNALS OF HEMATOLOGY, 2002, 81 (03) : 125 - 135
  • [27] Nuclear Syndecan-1 Regulates Epithelial-Mesenchymal Plasticity in Tumor Cells
    Kumar-Singh, Ashish
    Parniewska, Malgorzata Maria
    Giotopoulou, Nikolina
    Javadi, Joman
    Sun, Wenwen
    Szatmari, Tunde
    Dobra, Katalin
    Hjerpe, Anders
    Fuxe, Jonas
    BIOLOGY-BASEL, 2021, 10 (06):
  • [28] Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma
    Rintala, M
    Inki, P
    Klemi, P
    Jalkanen, M
    Grénman, S
    GYNECOLOGIC ONCOLOGY, 1999, 75 (03) : 372 - 378
  • [29] Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma
    Yablecovitch, Doron
    Ben-Horin, Shomron
    Picard, Orit
    Yavzori, Miri
    Fudim, Ella
    Nadler, Moshe
    Levy, Idan
    Sakhnini, Emad
    Lang, Alon
    Engel, Tal
    Lahav, Maor
    Saker, Talia
    Neuman, Sandra
    Selinger, Limor
    Dvir, Revital
    Raitses-Gurevich, Maria
    Golan, Talia
    Laish, Ido
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2022, 13 (05)
  • [30] Loss of Syndecan-1 Is Associated With Malignant Conversion in Skin Carcinogenesis
    Stepp, Mary Ann
    Pal-Ghosh, Sonali
    Tadvalkar, Gauri
    Rajjoub, Lamise
    Jurjus, Rosalyn A.
    Gerdes, Michael
    Ryscavage, Andrew
    Cataisson, Christophe
    Shukla, Anjali
    Yuspa, Stuart H.
    MOLECULAR CARCINOGENESIS, 2010, 49 (04) : 363 - 373
12345